Micro-HCCs in rats with liver cirrhosis: paradoxical targeting effects with vascular disrupting agent CA4P

We sought to investigate anticancer efficacy of a vascular disrupting agent (VDA) combretastatin A-4 phosphate (CA4P) in relation to tumor size among hepatocellular carcinomas (HCCs) in rats using magnetic resonance imaging (MRI) and postmortem techniques. Nineteen rats with 43 chemically-induced HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yewei, Yin, Ting, Keyzer, Frederik De, Feng, Yuanbo, Chen, Feng, Liu, Jianjun, Song, Shaoli, Yu, Jie, Vandecaveye, Vincent, Swinnen, Johan, Bormans, Guy, Himmelreich, Uwe, Oyen, Raymond, Zhang, Jian, Huang, Gang, Ni, Yicheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589653/
https://www.ncbi.nlm.nih.gov/pubmed/28903414
http://dx.doi.org/10.18632/oncotarget.19339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589653/
https://www.ncbi.nlm.nih.gov/pubmed/28903414
http://dx.doi.org/10.18632/oncotarget.19339

Ejemplares similares